Cellosaurus logo
expasy logo

Cellosaurus JVM-13 (CVCL_1318)

[Text version]
Cell line name JVM-13
Synonyms JVM 13; JVM13
Accession CVCL_1318
Resource Identification Initiative To cite this cell line use: JVM-13 (RRID:CVCL_1318)
Comments Part of: LL-100 blood cancer cell line panel.
Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
Part of: MD Anderson Cell Lines Project.
Doubling time: 58 hours (PubMed=25315077); ~70 hours (DSMZ=ACC-19).
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Omics: Deep exome analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
HLA typing Source: PubMed=25960936
Class I
HLA-AA*02:01,03:01
HLA-BB*15:01,56:01
HLA-CC*01:02,03:03
Class II
HLA-DQDQA1*01:03,01:03
DQB1*06:03,06:03
HLA-DRDRB1*13:01,03:38

Source: DSMZCellDive=ACC-19
Class I
HLA-AA*02:01:01,03:01:01
HLA-BB*15:01:01,56:01:01
HLA-CC*01:02:01,03:03:01
Class II
HLA-DPDPA1*01:03:01,01:03:01
DPB1*04:01:01,06:01
HLA-DQDQA1*01:03:01,01:03:01
DQB1*06:03:01,06:03:01
HLA-DRDRA*01:02:02,01:02:02
DRB1*13:01:01,13:01:01
Disease Mantle cell lymphoma (NCIt: C4337)
Mantle cell lymphoma (ORDO: Orphanet_52416)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 60-69Y
Category Transformed cell line
STR profile Source(s): ATCC=CRL-3003; DSMZ=ACC-19; ECACC=96090516

Markers:
AmelogeninX,Y
CSF1PO10,12
D2S133818,20
D3S135815,19
D5S81811
D7S8209
D8S117913,13.2
D13S3179,11
D16S53911
D18S5114,19
D19S43314
D21S1129
FGA22,24
Penta D10
Penta E9,10
TH016,7
TPOX10,11
vWA16,18

Run an STR similarity search on this cell line
Web pages https://tcpaportal.org/mclp/
Publications

PubMed=3262465; PMCID=PMC1541467
Vaz de Melo J., Foroni L., Brito-Babapulle V., Luzzatto L., Catovsky D.
The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.
Clin. Exp. Immunol. 73:23-28(1988)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=20454443; DOI=10.1155/2010/904767; PMCID=PMC2861168
Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.
J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010)

PubMed=24362935; DOI=10.1038/nm.3435
Rahal R., Frick M., Romero R., Korn J.M., Kridel R., Chan F.C., Meissner B., Bhang H.-E.C., Ruddy D., Kauffmann A., Farsidjani A., Derti A., Rakiec D., Naylor T., Pfister E., Kovats S., Kim S., Dietze K., Dorken B., Steidl C., Tzankov A., Hummel M., Monahan J.E., Morrissey M.P., Fritsch C., Sellers W.R., Cooke V.G., Gascoyne R.D., Lenz G., Stegmeier F.
Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma.
Nat. Med. 20:87-92(2014)

PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)

PubMed=25315077; DOI=10.3109/10428194.2014.970548
Fogli L.K., Williams M.E., Connors J.M., Reid Y.A., Brown K., O'Connor O.A.
Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection.
Leuk. Lymphoma 56:2114-2122(2015)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

PubMed=29666304; DOI=10.1158/1078-0432.CCR-17-3004
Pham L.V., Huang S.-J., Zhang H., Zhang J., Bell T., Zhou S.-H., Pogue E., Ding Z.-Y., Lam L., Westin J., Davis R.E., Young K.H., Medeiros L.J., Ford R.J. Jr., Nomie K., Zhang L., Wang M.
Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas.
Clin. Cancer Res. 24:3967-3980(2018)

PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646
Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.
The LL-100 panel: 100 cell lines for blood cancer studies.
Sci. Rep. 9:8218-8218(2019)

Cross-references
Cell line collections (Providers) ATCC; CRL-3003
DSMZ; ACC-19
ECACC; 96090516
Cell line databases/resources CLO; CLO_0007046
CLDB; cl2964
CLDB; cl5073
DSMZCellDive; ACC-19
Biological sample resources BioSample; SAMN01821571
BioSample; SAMN01821641
BioSample; SAMN03471707
Encyclopedic resources Wikidata; Q54899190
Gene expression databases ArrayExpress; E-MTAB-7721
ArrayExpress; E-MTAB-7722
GEO; GSM1266785
GEO; GSM1266786
Entry history
Entry creation04-Apr-2012
Last entry update02-May-2024
Version number25